Clinical Trial Update: Adjunctive Therapy of Exenatide or Sitagliptin to Insulin Glargine in Type 2 Diabetes [Phase 1]

View source ↗

Summary

A Phase 1 trial assessing adjunctive therapy with exenatide or sitagliptin added to insulin glargine in adults with type 2 diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• EXENATIDE (EXENATIDE)
• Sitagliptin (sitagliptin)

Snippet

Sponsor: Profil Institut für Stoffwechselforschung GmbH | Conditions: Type 2 Diabetes | Phase 1 | Status: COMPLETED